Adage Capital Partners Gp, L.L.C. Glycomimetics Inc Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Glycomimetics Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 5,091,231 shares of GLYC stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,091,231Holding current value
$1.48 Million% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding GLYC
# of Institutions
37Shares Held
27.3MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA9.54MShares$2.77 Million0.09% of portfolio
-
Logos Global Management LP San Francisco, CA5.4MShares$1.57 Million0.18% of portfolio
-
Vr Adviser, LLC New York, NY3MShares$869,9990.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$774,3600.0% of portfolio
-
Wellington Management Group LLP Boston, MA1.41MShares$409,8860.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $15.2M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...